Similar articles

• Enhancement of tumour growth by lymphoid cells from mice treated with antilymphocyte globulin.

  Shellam GR, Fahey KJ. Shellam GR, et al. Adv Exp Med Biol. 1973;29(0):411-7. doi: 10.1007/978-1-4615-9017-0_60. Adv Exp Med Biol. 1973. PMID: 4211985 No abstract available.
• Cellular immune response against tumor cells. I. In vitro immunization of allogeneic and syngeneic mouse spleen cell suspensions against DBA mastocytoma cells.

  Lundak RL, Raidt DJ. Lundak RL, et al. Cell Immunol. 1973 Oct;9(1):60-6. doi: 10.1016/0008-8749(73)90167-6. Cell Immunol. 1973. PMID: 4270287 No abstract available.
• In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.

  Rouse BT, Wagner H, Harris AW. Rouse BT, et al. J Immunol. 1972 May;108(5):1353-61. J Immunol. 1972. PMID: 4623947 No abstract available.
• Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

  Hellström KE, Hellström I. Hellström KE, et al. Adv Immunol. 1974;18:209-77. doi: 10.1016/s0065-2776(08)60311-9. Adv Immunol. 1974. PMID: 4597622 Review. No abstract available.
• On T-cell-mediated cytotoxicity.

  Golstein P, Blomgren H, Svedmyr EA, Wigzell H. Golstein P, et al. Transplant Proc. 1973 Dec;5(4):1441-5. Transplant Proc. 1973. PMID: 4204523 Review. No abstract available.